Patents by Inventor Jürgen Lutz

Jürgen Lutz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210177749
    Abstract: A solid oral pharmaceutical composition for delivery of a pharmaceutically acceptable active ingredient to an animal where the composition comprises an isoxazoline compound, a solvent and an excipient, a process for the manufacture of such solid oral pharmaceutical composition and a method of controlling a parasite infection administering such solid oral pharmaceutical composition.
    Type: Application
    Filed: March 2, 2021
    Publication date: June 17, 2021
    Applicant: Intervet Inc.
    Inventors: Keith Freehauf, Niki Waldron, Jürgen Lutz, Frank Guerino
  • Publication number: 20210061775
    Abstract: This invention relates to methods for controlling parasitic infestations of animals and their environments, and, more particularly, to methods using isoxazolines to control parasites in or on animals or in their environments, as well as treat parasitoses of animals. The isoxazolines include 4-(isoxazolinyl)-benzamides (specifically, substituted 4-(5-(halomethyl)-5-phenyl-isoxazolin-3-yl)-benzamides) and 4-(isoxazolinyl)-benzothioamides (specifically, substituted 4-(5-(halomethyl)-5-phenyl-isoxazolin-3-yl)-benzothioamides). This invention also relates to compositions comprising the isoxazolines for use in such methods, the use of the isoxazolines to make medicaments for use in such methods, and kits comprising the isoxazolines for carrying out such methods. This invention further relates to the use of the isoxazolines as medicaments, particularly medicaments that can be used in the above-referenced method.
    Type: Application
    Filed: September 15, 2020
    Publication date: March 4, 2021
    Applicant: Intervet Inc.
    Inventors: Anja Regina Heckeroth, Jürgen Lutz, Christina Mertens, Heike Williams, Hartmut Zoller, Takeshi Mita
  • Publication number: 20200000718
    Abstract: A solid oral pharmaceutical composition for delivery of a pharmaceutically acceptable active ingredient to an animal where the composition comprises an isoxazoline compound, a solvent and an excipient, a process for the manufacture of such solid oral pharmaceutical composition and a method of controlling a parasite infection administering such solid oral pharmaceutical composition.
    Type: Application
    Filed: July 11, 2019
    Publication date: January 2, 2020
    Applicant: Intervet Inc.
    Inventors: Keith Freehauf, Niki Waldron, Jürgen Lutz, Frank Guerino
  • Publication number: 20190201332
    Abstract: A soft chewable pharmaceutical product for delivery of a pharmaceutically acceptable active ingredient to an animal comprising pamoic acid or a pharmaceutically acceptable salt and a process for the manufacture of such soft chewable pharmaceutical product.
    Type: Application
    Filed: March 8, 2019
    Publication date: July 4, 2019
    Applicant: Intervet Inc.
    Inventors: Susi Alteheld, Stefan Fuchs, Carina Hang, Jürgen Lutz
  • Publication number: 20190117564
    Abstract: A soft chewable pharmaceutical product for delivery of a pharmaceutically acceptable active ingredient to an animal comprising pamoic acid or a pharmaceutically acceptable salt and a process for the manufacture of such soft chewable pharmaceutical product.
    Type: Application
    Filed: May 17, 2018
    Publication date: April 25, 2019
    Applicant: Intervet Inc.
    Inventors: Rainer Roepke, Carsten Schmidt, Susi Alteheld, Carina Hang, Stefan Fuchs, Jürgen Lutz
  • Publication number: 20180155301
    Abstract: This invention relates to methods for controlling parasitic infestations of animals and their environments, and, more particularly, to methods using isoxazolines to control parasites in or on animals or in their environments, as well as treat parasitoses of animals. The isoxazolines include 4-(isoxazolinyl)-benzamides (specifically, substituted 4-(5-(halomethyl)-5-phenyl-isoxazolin-3-yl)-benzamides) and 4-(isoxazolinyl)-benzothioamides (specifically, substituted 4-(5-(halomethyl)-5-phenyl-isoxazolin-3-yl)-benzothioamides). This invention also relates to compositions comprising the isoxazolines for use in such methods, the use of the isoxazolines to make medicaments for use in such methods, and kits comprising the isoxazolines for carrying out such methods. This invention further relates to the use of the isoxazolines as medicaments, particularly medicaments that can be used in the above-referenced method.
    Type: Application
    Filed: January 26, 2018
    Publication date: June 7, 2018
    Applicant: Intervet Inc.
    Inventors: Anja Regina Heckeroth, Jürgen Lutz, Christina Mertens, Heike Williams, Hartmut Zoller, Takeshi Mita
  • Publication number: 20170290766
    Abstract: A soft chewable pharmaceutical product for delivery of a pharmaceutically acceptable active ingredient to an animal comprising pamoic acid or a pharmaceutically acceptable salt and a process for the manufacture of such soft chewable pharmaceutical product.
    Type: Application
    Filed: June 27, 2017
    Publication date: October 12, 2017
    Applicant: Intervet, Inc.
    Inventors: Susi Alteheld, Stefan Fuchs, Carina Hang, Jürgen Lutz
  • Patent number: 9770440
    Abstract: A solid oral pharmaceutical composition for delivery of a pharmaceutically acceptable active ingredient to an animal where the composition comprises an isoxazoline compound, a solvent and an excipient, a process for the manufacture of such solid oral pharmaceutical composition and a method of controlling a parasite infection administering such solid oral pharmaceutical composition.
    Type: Grant
    Filed: April 3, 2013
    Date of Patent: September 26, 2017
    Assignee: Intervet Inc.
    Inventors: Keith Freehauf, Niki Waldron, Jürgen Lutz, Frank Guerino
  • Publication number: 20170266165
    Abstract: A soft chewable pharmaceutical product for delivery of a pharmaceutically acceptable active ingredient to an animal comprising pamoic acid or a pharmaceutically acceptable salt and a process for the manufacture of such soft chewable pharmaceutical product.
    Type: Application
    Filed: June 5, 2017
    Publication date: September 21, 2017
    Applicant: Intervet Inc.
    Inventors: Susi Alteheld, Stefan Fuchs, Carina Hang, Jürgen Lutz
  • Publication number: 20170172918
    Abstract: A soft chewable pharmaceutical product for delivery of a pharmaceutically acceptable active ingredient to an animal comprising pamoic acid or a pharmaceutically acceptable salt and a process for the manufacture of such soft chewable pharmaceutical product.
    Type: Application
    Filed: February 15, 2017
    Publication date: June 22, 2017
    Applicant: Intervet, Inc.
    Inventors: Susi Alteheld, Stefan Fuchs, Carina Hang, Jürgen Lutz
  • Publication number: 20170172986
    Abstract: A soft chewable pharmaceutical product for delivery of a pharmaceutically acceptable active ingredient to an animal comprising pamoic acid or a pharmaceutically acceptable salt and a process for the manufacture of such soft chewable pharmaceutical product.
    Type: Application
    Filed: February 15, 2017
    Publication date: June 22, 2017
    Applicant: Intervet, Inc.
    Inventors: Susi Alteheld, Stefan Fuchs, Carina Hang, Jürgen Lutz
  • Publication number: 20170105972
    Abstract: A soft chewable pharmaceutical product for delivery of a pharmaceutically acceptable active ingredient to an animal comprising pamoic acid or a pharmaceutically acceptable salt and a process for the manufacture of such soft chewable pharmaceutical product.
    Type: Application
    Filed: December 23, 2016
    Publication date: April 20, 2017
    Applicant: Intervet, Inc.
    Inventors: Susi Alteheld, Stefan Fuchs, Carina Hang, Jürgen Lutz
  • Publication number: 20170100377
    Abstract: A solid oral pharmaceutical composition for delivery of a pharmaceutically acceptable active ingredient to an animal where the composition comprises an isoxazoline compound, a solvent and an excipient, a process for the manufacture of such solid oral pharmaceutical composition and a method of controlling a parasite infection administering such solid oral pharmaceutical composition.
    Type: Application
    Filed: December 21, 2016
    Publication date: April 13, 2017
    Applicant: Intervet Inc.
    Inventors: Keith Freehauf, Niki Waldron, Jürgen Lutz, Frank Guerino
  • Patent number: 9598412
    Abstract: This invention relates to spiroindoline compounds for the treatment of helminth infections and the treatment of parasitosis, such as caused by helminth infections. This invention also relates to uses of the compounds to make medicaments and treatments comprising the administration of the compounds to animals in need of the treatments. Moreover this invention relates to pharmaceutical compositions and kits comprising the compounds.
    Type: Grant
    Filed: October 14, 2014
    Date of Patent: March 21, 2017
    Assignee: Intervet Inc.
    Inventors: Jürgen Lutz, Sandra Koch, Manfred Uphoff, Anja Regina Heckeroth, Britta von Oepen, Ulrich Sondern, Christophe Pierre Alain Chassaing
  • Publication number: 20160332975
    Abstract: This invention relates to methods for controlling parasitic infestations of animals and their environments, and, more particularly, to methods using isoxazolines to control parasites in or on animals or in their environments, as well as treat parasitoses of animals. The isoxazolines include 4-(isoxazolinyl)-benzamides (specifically, substituted 4-(5-(halomethyl)-5-phenyl-isoxazolin-3-yl)-benzamides) and 4-(isoxazolinyl)-benzothioamides (specifically, substituted 4-(5-(halomethyl)-5-phenyl-isoxazolin-3-yl)-benzothioamides). This invention also relates to compositions comprising the isoxazolines for use in such methods, the use of the isoxazolines to make medicaments for use in such methods, and kits comprising the isoxazolines for carrying out such methods. This invention further relates to the use of the isoxazolines as medicaments, particularly medicaments that can be used in the above-referenced method.
    Type: Application
    Filed: July 28, 2016
    Publication date: November 17, 2016
    Applicant: Intervet Inc.
    Inventors: Anja Regina Heckeroth, Jürgen Lutz, Christina Mertens, Heike Williams, Hartmut Zoller, Takeshi Mita
  • Patent number: 9096599
    Abstract: This invention relates to novel spiroindoline compounds of formula (I) that are generally useful as medicaments, more specifically as medicaments for animals. The medicament can preferably be used for the treatment of helminth infections and the treatment of parasitosis, such as caused by helminth infections. This invention also relates to uses of the compounds to make medicaments and treatments comprising the administration of the compounds to animals in need of the treatments. This invention also relates to the preparation of said compounds. Moreover this invention relates to pharmaceutical compositions and kits comprising the compounds.
    Type: Grant
    Filed: August 3, 2012
    Date of Patent: August 4, 2015
    Assignee: Intervet Inc.
    Inventors: Christophe Pierre Alain Chassaing, Sandra Koch, Jürgen Lutz
  • Publication number: 20150111936
    Abstract: This invention relates to methods for controlling parasitic infestations of animals and their environments, and, more particularly, to methods using isoxazolines to control parasites in or on animals or in their environments, as well as treat parasitoses of animals. The isoxazolines include 4-(isoxazolinyl)-benzamides (specifically, substituted 4-(5-(halomethyl)-5-phenyl-isoxazolin-3-yl)-benzamides) and 4-(isoxazolinyl)-benzothioamides (specifically, substituted 4-(5-(halomethyl)-5-phenyl-isoxazolin-3-yl)-benzothioamides). This invention also relates to compositions comprising the isoxazolines for use in such methods, the use of the isoxazolines to make medicaments for use in such methods, and kits comprising the isoxazolines for carrying out such methods. This invention further relates to the use of the isoxazolines as medicaments, particularly medicaments that can be used in the above-referenced methods.
    Type: Application
    Filed: December 22, 2014
    Publication date: April 23, 2015
    Inventors: Anja Regina Heckeroth, Jürgen Lutz, Christina Mertens, Heike Williams, Hartmut Zoller, Takeshi Mita
  • Publication number: 20150057239
    Abstract: A solid oral pharmaceutical composition for delivery of a pharmaceutically acceptable active ingredient to an animal where the composition comprises an isoxazoline compound, a solvent and an excipient, a process for the manufacture of such solid oral pharmaceutical composition and a method of controlling a parasite infection administering such solid oral pharmaceutical composition.
    Type: Application
    Filed: April 3, 2013
    Publication date: February 26, 2015
    Inventors: Keith Freehauf, Niki Waldron, Jürgen Lutz, Frank Guerino
  • Patent number: D826742
    Type: Grant
    Filed: December 19, 2016
    Date of Patent: August 28, 2018
    Assignee: Robert Bosch GmbH
    Inventor: Juergen Lutz
  • Patent number: D830398
    Type: Grant
    Filed: May 10, 2017
    Date of Patent: October 9, 2018
    Assignee: Robert Bosch GmbH
    Inventor: Juergen Lutz